🩸🔍First question of the month!

Swipe to see the answer and its explanation.

#CMML #ChronicMyelomonocyticLeukemia #Hematology #MyeloidNeoplasms #ClonalHematopoiesis #CHIP #TET2 #SRSF2 #ASXL1 #BoneMarrow #Monocytosis #FlowCytometry #HematologicMalignancies #HemeEd #HemeHub #BloodCancer

🩸Facts about Chronic Myelomonocytic Leukemia:

Disease Biology & Pathogenesis

#CMML #MDS #MPN #Hematology #HematologicMalignancies #ClonalHematopoiesis #CHIP #TET2 #SRSF2 #ASXL1 #MyeloidNeoplasms #MedEd #HemeEd #HemeHub #BloodCancer #MyeloidDisorders #ClinicalHematology

🌐Enhance your hematology knowledge with HemeHub webinars, available anytime.

All past sessions are organized by topic directly on our website and are also available on YouTube.

🔗 Learn more at hemehub.org

#HemeHub #Hematology #HemeEd #HemeOnc #BMF #Lymphoma #BleedingDisorders #ThromboticDisorders

📌Session Update

🩸Our Multiple Myeloma session, previously postponed, has now been scheduled for April 10th!

🔗Register: hemehub.org/live-webinars
🔗Case submissions: hemehub.org/case-submiss...

#MultipleMyeloma #Hematology #Oncology
@mskcancercenter.bsky.social @utswim.bsky.social

#PedsHemeOnc #PHODocs #Pediatric #Hematology #Oncology #PeterNewburger

Efficacy and Safety of First-Line Acalabrutinib Plus Venetoclax Revamps QOL Outcomes in CLL | OncLive Jennifer R. Brown, MD, PhD, discusses the FDA approval of acalabrutinib plus venetoclax for chronic lymphocytic leukemia and how it improves QOL.

Jennifer R. Brown, MD, PhD, discusses the FDA approval of acalabrutinib plus venetoclax for chronic lymphocytic leukemia and how it improves QOL. @danafarber.bsky.social #leusm #hematology #oncology
www.onclive.com/view/efficac...

U01.01.085 Vitamin K A deep dive into U01.01.085 Vitamin K. Understand the Vitamin K epoxide reductase cycle, the role of gamma-carboxyglutamic acid in calcium binding, and why newborns are at risk for life-threatening bleeds without supplementation.

🩸 The Clotting Catalyst: Mastering Vitamin K! 🩸
#USMLEStep1 #MedEd #MedicalStudent #Biochemistry #VitaminK #Hematology #ClottingCascade #Warfarin #Step1Prep #HighYield #MedSchool #Pediatrics #NeonatalCare #USMLE #FutureDoctor #StudyGram #MedTwitter

U01.01.084 Vitamin E A deep dive into U01.01.084 Vitamin E. Understand the antioxidant mechanisms protecting polyunsaturated fatty acids, the clinical signs of demyelination in the posterior columns, and the risks of high-dose supplementation in patients on anticoagulants.

🛡️ The Membrane Protector: Mastering Vitamin E (Tocopherol)! 🛡️
#USMLEStep1 #MedEd #MedicalStudent #Biochemistry #VitaminE #Tocopherol #Step1Prep #HighYield #MedSchool #Hematology #Neurology #Antioxidant #USMLE #FutureDoctor #StudyGram #MedTwitter

#PBC Must Read: Group 4 #Medulloblastomas of Early Childhood Treated With High-Dose #Chemotherapy- and #Craniospinal Irradiation-Sparing Approach #Pediatric
#Oncology #Hematology #PedsHemeOnc #PHODocs #PatriciaOrduña #RoseDaynielleCansanay #CraigErker
onlinelibrary.wiley.com/doi/10.1002/...

Orca-T Diversifies Well-Tolerated Post-Transplant Treatment Options for Hematologic Malignancies | OncLive Sagar S. Patel, MD, discusses data from a retrospective analysis of Orca-T and PTCy for hematologic malignancies and its implications for the field.

Sagar S. Patel, MD, discusses data from a retrospective analysis of Orca-T and PTCy for hematologic malignancies and its implications for the field. @huntsmancancer.bsky.social @astct.bsky.social @cibmtr.bsky.social #Tandem2026 #leusm #hematology
www.onclive.com/view/orca-t-...

Join leading policy and field experts at #ASPHO2026 for a timely #advocacy session, "Shaping Policy, Protecting Patients," and learn how current policy and funding decisions are impacting #pediatric #hematology and #oncology, research, and access for patients.
Register: aspho.org/meetings/con...

🇬🇧 Congrats to Alexia Kinoo for the SFH 2026 award! 🏆

Her work reveals a key role for ZEB1 in terminal erythroid maturation via the GATA2-KLF1 regulatory switch.

Great team effort from @soler-lab.bsky.social and @herminelab.bsky.social

#hematology #geneRegulation

Third-Line Therapy Shows Limited Efficacy in Real-World aGVHD Population | CancerNetwork The real-world CHRONOS study may set a new benchmark for the third-line management of acute graft-versus-host-disease with gastrointestinal involvement.

📰 #Media – We’re pleased to share that the real‑world CHRONOS study, the largest evaluation to date of third‑line therapy in GI-aGVHD, has just been featured in CancerNetwork.

👉 Read the article here: www.cancernetwork.com/view/third-l...

#Microbiome #Microbiotherapy #aGvHD #Hematology #Oncology

FDA Approves Brexu-Cel for Relapsed/Refractory MCL | OncLive OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

🚨 BREAKING NEWS: The @fda.gov has granted traditional approval to brexucabtagene autoleucel for the treatment of adult patients with relapsed/refractory mantle cell lymphoma. #oncology #MCL #hematology
Here's what you should know about the decision: www.onclive.com/view/fda-app...

Join the IAHAD Webinar (37th Series) on 10 April, 6:30 PM IST
Topic: Practical Diagnosis of von Willebrand Disease
Dr. Jasmina Ahluwalia
Dr. Dinesh Chandra
Panel: Dr. Rajesh Phatale | Dr. Tulasi Geevar | Dr. Jasmita
miceideas.org/webinar/regi...
#Hematology #vWD #MedicalEducation #IAHAD

🩸Final Questions on Myelofibrosis! Swipe to see the answers and their explanations.

Stay tuned for our next question series on Chronic Myelomonocytic Leukemia (CMML)!

#Myelofibrosis #MF #HemeHub #Hematology #HemOnc #MyeloidNeoplasms #BoneMarrowFibrosis #Anemia #Momelotinib #BloodDisorders #HEMEHUB

🩸 This Month on HemeHub: Chronic Myelomonocytic Leukemia (CMML)

Join us as we explore disease biology & pathogenesis, diagnosis, prognostic scoring, and treatment strategies in Chronic Myelomonocytic Leukemia.

#CMML #HemeHub #Hematology #HemOnc #MyeloidNeoplasms #BloodDisorders #HEMEHUB

Happening this Friday!

🔗Register: hemehub.org/live-webinars
🔗Submit your cases: hemehub.org/case-submiss...

#CMML #Hematology #HematologyEducation #BloodDisorders #Leukemia #MedEd #HemeOnc #ClinicalCases #PatientCases #BloodCancer #HEMEHUB
@mayoclinic.org @clevelandclinic.bsky.social

#Pediatric #Hematology #Oncology #Hemoglobinapothies #BloodDisorders

U01.01.081 Vitamin B12 Test your knowledge of Vitamin B12. Practice identifying the causes of B12 deficiency—from veganism to Diphyllobothrium latum—and master the laboratory findings of elevated Methylmalonic Acid (MMA) and Homocysteine.

🧬 The Cobalt Core: Mastering Vitamin B12 (Cobalamin)! 🧬
#USMLEStep1 #MedEd #MedicalStudent #Biochemistry #VitaminB12 #Cobalamin #Step1Prep #HighYield #MedSchool #Hematology #Neurology #PerniciousAnemia #USMLE #FutureDoctor #StudyGram #MedTwitter

U01.01.080 Vitamin B9 Test your knowledge of U01.01.080 Vitamin B9. Practice identifying the role of Dihydrofolate Reductase, the impact of drugs like Methotrexate and Phenytoin, and the classic laboratory findings of megaloblastic anemia.

🌱 The One-Carbon Master: Mastering Vitamin B9 (Folate)! 🌱
#USMLEStep1 #MedEd #MedicalStudent #Biochemistry #VitaminB9 #Folate #Step1Prep #HighYield #MedSchool #Hematology #OBGYN #Anemia #USMLE #FutureDoctor
Folate is the essential engine behind DNA and RNA synthesis, making it one of the most clin

U01.01.078 Vitamin B6 Test your knowledge of U01.01.078 Vitamin B6. Practice identifying the role of PLP in neurotransmitter synthesis, heme production, and the management of INH-induced peripheral neuropathy with this expert-curated MCQ set.

🧠 The Versatile Cofactor: Mastering Vitamin B6 (Pyridoxine)! 🧠
#USMLEStep1 #MedEd #MedicalStudent #Biochemistry #VitaminB6 #Pyridoxine #Step1Prep #HighYield #MedSchool #Hematology #Neurology #Isoniazid #USMLE #FutureDoctor #StudyGram #MedTwitter
Vitamin B6 (as PLP) is perhaps the most versatile co

📰 #PressRelease – MaaT Pharma announces publication of retrospective data from CHRONOS, a large real-world third-line GI-aGvHD study (n=59), in Bone Marrow Transplantation Journal.

🔗 Read the full press release: www.maatpharma.com/april-1st-20...

#Biotech #Hematology #aGvHD #GvHD #Microbiome

#ASPHO2026 #PedsHemeOnc #PHODocs #Pediatric #Hematology #Oncology #BloodDisorders #HemeSky #MedSky

Trying to find the ideal candidate for your open #hematology position?

Post your job listing to the ASH Job Center and connect to thousands of qualified hematology and hematology-oncology professionals. https://ow.ly/23e050YBgpK

#Jobsearch #HematologyJobs #MedSky #HemeSky

Lymphoid Neoplasms and COVID-19 Vaccination It is established that administration of the COVID-19 vaccine may be associated with an exaggerated immune response leading to enlargement of several lymph nodes. Although most cases are benign and self-limiting, some have been reported in the literature as B-cell or T-cell lymphomas, with no reported cases of chronic lymphocytic leukaemia (CLL). We report two cases of follicular lymphoma and CLL that occurred a few weeks after COVID-19 vaccination. Case 1 is a 48-year-old woman who noticed two significantly palpable masses, one in each axilla, 48 h after receiving the first dose of the Pfizer-BioNTech BNT162b2 vaccine for COVID-19. Seven days later, she noticed another mass on the right side of her neck, which was biopsied within 48 hours. Case 2 is a 75-year-old man who presented with localized swellings in the axilla and on the neck, noted 24 h after the first dose of the Moderna messenger RNA-1273 COVID-19 vaccine. Neither patient reported any constitutional or associated symptoms. Surgical biopsy of the axillary lymph node in case 1 revealed a non-Hodgkin lymphoma, confirmed via immunohistochemistry as CD20-positive B-cell follicular lymphoma. The patient also had multiple pre- and para-aortic lymph nodes. In case 2, complete blood count showed lymphocytosis (total white blood cell – 148 × 109/L; lymphocyte differential – 92%), while peripheral blood film showed lymphocytosis with a predominance of small, mature-looking lymphocytes, both suggesting CLL. Although requested, immunophenotyping and molecular testing were not performed due to patient-related challenges. Although a chance occurrence is possible, lymphoid malignancies should be considered a strong differential. The vaccination history of patients presenting with clinical manifestations suggestive of a lymphoid malignancy should be thoroughly investigated, while ruling out other possible differentials such as a benign, self-limiting inflammatory process.

🎗️ COVID-19 vaccination can complicate lymph node interpretation in patients with lymphoid neoplasms-a timely reminder for careful clinical context. @cancerresearchuk.org
#Hematology
🔗 www.xiahepublishing.com/2996-3427/On...

AI Tools Could Drive Improved Risk Stratification, Treatment Decision-Making in Multiple Myeloma | OncLive C. Ola Landgren, MD, PhD, discusses the development of the AI risk-stratification model CORAL and its potential role in individualizing myeloma care.

C. Ola Landgren, MD, PhD, discusses the development of the AI risk-stratification model CORAL and its potential role in individualizing myeloma care. #mmsm #hematology #oncology
www.onclive.com/view/ai-tool...

🩸 #sfh2026 #Hematology #OncoHematology #Waldenström #IWMF #Immunology #Lymphoma #WomenInSTEM #GustaveRoussy #WeillCornell #StemCells #ApostolouLab #MelnickLab

🩸 Program details are now available for our HemeHub Hematology Summit!

Join us at the Gaylord Texan Center for an expert-led, practice-focused hematology program in collaboration with Texas Oncology.

🔗 Explore the full program and event details: hemehub.org/hybrid-event...

#HemeHub #Hematology

🩸Today’s questions!

Swipe to see the answers and their explanations.

#Hematology #ClinicalHematology #Myelofibrosis #PolycythemiaVera #MyeloproliferativeNeoplasms #MPN #PostPVMF #BoneMarrowDisorders #Splenomegaly #Leucoerythroblastosis #HemeOnc #MedEd #HemeHub #ACVR1 #ALK2